A phase 2 trial of cabozantinib in ROS1-rearranged lung adenocarcinoma Meeting Abstract


Authors: Guo, R.; Preeshagul, I.; Schoenfeld, A.; McCarthy, C.; Makhnin, A.; Plodkowski, A.; Ginsberg, M.; Davare, M.; Delasos, L.; Somwar, R.; Arcila, M.; Riely, G.; Rekhtman, N.; Ladanyi, M.; Kris, M.; Drilon, A.
Abstract Title: A phase 2 trial of cabozantinib in ROS1-rearranged lung adenocarcinoma
Meeting Title: 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC)
Keywords: lung adenocarcinoma; cabozantinib; ros1
Journal Title: Journal of Thoracic Oncology
Volume: 14
Issue: 10 Suppl.
Meeting Dates: 2019 Sept 7-10
Meeting Location: Barcelona, Spain
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: S574
End Page: S575
Language: English
ACCESSION: WOS:000492162203117
DOI: 10.1016/j.jtho.2019.08.1201
PROVIDER: wos
Notes: Meeting Abstract: P1.14-50 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    424 Rekhtman
  2. Michelle S Ginsberg
    235 Ginsberg
  3. Marc Ladanyi
    1326 Ladanyi
  4. Romel Somwar
    110 Somwar
  5. Maria Eugenia Arcila
    657 Arcila
  6. Mark Kris
    869 Kris
  7. Alexander Edward Drilon
    632 Drilon
  8. Robin Guo
    24 Guo
  9. Alex Makhnin
    19 Makhnin